Lane Neidig, MD
Dermatology · Annapolis, MDNPI 1851779573
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 561 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,677, more than ten times the $75 reported in 2019.
Across 561 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$1K
- Incyte Corporation$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sun Pharmaceutical Industries Inc.$966
- Sanofi$834
- plus $6K from 29 others
What the payments were for
- Food & beverage$11,84996%
- Education$5324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 74 | $1,355 |
| AbbVie | 48 | $1,073 |
| Incyte Corporation | 41 | $1,051 |
| Regeneron Healthcare Solutions, Inc. | 39 | $1,022 |
| Sun Pharmaceutical Industries Inc. | 31 | $966 |
| Sanofi | 30 | $834 |
| Pfizer | 44 | $828 |
| Dermavant Sciences, Inc. | 42 | $760 |
| Lilly USA, LLC | 31 | $737 |
| Novartis | 26 | $520 |
| Arcutis Biotherapeutics, Inc. | 14 | $375 |
| UCB, Inc. | 18 | $371 |
| LEO Pharma Inc. | 14 | $339 |
| Galderma Laboratories, L.p. | 22 | $316 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 24 | $278 |
| Boehringer Ingelheim | 8 | $217 |
| E.r. Squibb & Sons, L.L.C. | 8 | $157 |
| Biofrontera Inc. | 7 | $153 |
| Verrica Pharmaceuticals Inc. | 2 | $147 |
| Mayne Pharma Commercial LLC | 7 | $112 |
| Organon | 4 | $109 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| Amgen | 4 | $86 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| LNHC, Inc | 3 | $60 |
| VYNE Pharmaceuticals Inc. | 3 | $56 |
| Kyowa Kirin, Inc. | 2 | $53 |
| Elekta, Inc. | 1 | $46 |
| Strata Skin Sciences, Inc. | 6 | $46 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $28 |
| Organogenesis Inc. | 1 | $26 |
| Dermira, Inc. | 1 | $24 |
| Botanix SB Inc | 1 | $22 |
| Almirall LLC | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,380 in reported general payments places this provider in the 80th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 16 | $61,184 |
| Clobetasol Propionate | 103 | $5,896 |
| Triamcinolone Acetonide | 143 | $2,429 |
| Ketoconazole | 97 | $1,636 |
| Clindamycin Phosphate | 30 | $1,265 |
| Mometasone Furoate | 26 | $636 |
| Fluocinonide | 23 | $613 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 14 | $607 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 13 | $543 |
| Betamethasone Dipropionate | 14 | $539 |
| Desonide | 11 | $410 |
| Hydrocortisone | 55 | $408 |
| Mupirocin | 36 | $356 |
| ValacyclovirValacyclovir Hcl | 14 | $297 |
| Hydroxychloroquine Sulfate | 15 | $240 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Annapolis
- Benjamin LockshinSilver Spring$4M
- Shawn KwatraBaltimore$1.1M
- Chesahna Kindred WeaverMarriottsville$837K
- Oanh LauringNottingham$763K
- Ronald PrussickN Bethesda$620K
- Rebecca KazinChevy Chase$342K
- Susan WalkerBethesda$221K
- Monte MeltzerBerlin$220K
- Valerie CallenderGlenn Dale$183K
- David StrobelCatonsville$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.